ArticlePest management science2026
Discovery of novel uridine-based chitin synthase inhibitors: Design, synthesis and structure-activity relationships.
Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundChitin synthase (CHS) enables the construction of fungi cell wall and insect skeleton by catalyzing the formation of chitin. CHS inhibitor (CHSI) disrupts the integrity of these structural barriers, leading to fungal cell lysis. Notably, CHSIs are considered non-toxic to vertebrates, making CHS a promising target for the development of novel antifungal agents.
resultsThirty-three novel uridine-based derivatives (UDs) were designed and synthesized through fragment-based drug design (FBDD) to discover potential CHSIs. Bioassays demonstrated that most of the synthesized compounds exhibited excellent fungicidal activity against Alternaria alternata and Botrytis cinerea, with inhibition rates exceeding 80% at 100 μg mL
conclusionCompound 5a is a promising antifungal agent with a unique mechanism of action by targeting fungal CHS. This study discovered a series of novel CHSIs with excellent fungicidal activities, offering valuable candidates for fungicide development. © 2026 Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.